BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21309700)

  • 1. Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine.
    Strawn JR; Whitsel R; Nandagopal JJ; Delbello MP
    J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):91-2. PubMed ID: 21309700
    [No Abstract]   [Full Text] [Related]  

  • 2. Duloxetine-induced life-threatening long QT syndrome.
    Štuhec M
    Wien Klin Wochenschr; 2013 Mar; 125(5-6):165-6. PubMed ID: 23440523
    [No Abstract]   [Full Text] [Related]  

  • 3. Duloxetine--three birds with one stone?
    Michel MC
    Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
    [No Abstract]   [Full Text] [Related]  

  • 4. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.
    Meighen KG
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):121-7. PubMed ID: 17343560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to duloxetine in a depressed, treatment-resistant adolescent female.
    Delgado SV; Saldaña SN; Barzman DH; Coffey B
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):889-94. PubMed ID: 18315460
    [No Abstract]   [Full Text] [Related]  

  • 6. Burning paresthesia related to duloxetine therapy.
    Woo YS; Bahk WM
    J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
    [No Abstract]   [Full Text] [Related]  

  • 7. Duloxetine.
    Preskorn SH
    J Psychiatr Pract; 2004 Nov; 10(6):375-85. PubMed ID: 15583519
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness and tolerability of duloxetine in 2 different ethnic samples: a prospective observational cohort study.
    Collazos F; Ramos M; Qureshi A; Eiroa-Orosa FJ; Rodriguez A; Castells X; Ribases M; Valero S; Casas M
    J Clin Psychopharmacol; 2013 Apr; 33(2):254-6. PubMed ID: 23422381
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of electroconvulsive therapy-duloxetine combination.
    Eraslan D; Genc Y; Odabasioglu G; Ergun BM; Ozturk O
    J ECT; 2011 Sep; 27(3):e51-2. PubMed ID: 21865952
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.
    Tomita T; Yasui-Furukori N; Kaneko S
    Clin Neuropharmacol; 2013; 36(5):175-6. PubMed ID: 24045610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe and symptomatic hyponatremia following duloxetine treatment.
    Müssig K; Mörike K; Häring HU
    J Psychopharmacol; 2009 May; 23(3):338-9. PubMed ID: 18562431
    [No Abstract]   [Full Text] [Related]  

  • 12. Duloxetine fights major depressive disorder.
    Wimett L; Laustsen G
    Nurse Pract; 2005 Mar; 30(3):6-7. PubMed ID: 15753808
    [No Abstract]   [Full Text] [Related]  

  • 13. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
    Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
    Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine-induced subcortical growth in a patient with major depressive disorder and panic disorder.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E42-3. PubMed ID: 21677225
    [No Abstract]   [Full Text] [Related]  

  • 15. [Brief case report. Duloxetine in Cotard syndrome].
    Kozian R
    Psychiatr Prax; 2005 Nov; 32(8):412-3. PubMed ID: 16342026
    [No Abstract]   [Full Text] [Related]  

  • 16. Reboxetine: a norepinephrine selective reuptake pump inhibitor.
    Preskorn SH
    J Psychiatr Pract; 2004 Jan; 10(1):57-63. PubMed ID: 15334987
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.
    Jimenez-Genchi A
    J Clin Psychiatry; 2006 Nov; 67(11):1821-2. PubMed ID: 17196070
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.
    Mancini M; Perna G; Rossi A; Petralia A
    Expert Opin Pharmacother; 2010 May; 11(7):1167-81. PubMed ID: 20402555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E40-1. PubMed ID: 21677224
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of pain and medication effect in a study of duloxetine.
    Griffith JM; Hasley JP; Severn DG
    J Clin Psychiatry; 2008 Jun; 69(6):1022. PubMed ID: 18684005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.